Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTK2B | Q14289 | 3/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.63 |
| ▸ | MEN1 | O00255 | 5/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ACLY | P53396 | 5/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | SLC16A3 | O15427 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 4/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | RAD52 | P43351 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14160305 | 0.86 | PTK2B (0.52) | PTK2BSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL2740945 | 0.83 | CRHBP (0.51) | PTK2BSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL2740961 | 0.81 | MEN1 (0.51) | PTK2BSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL13128919 | 0.76 | MEN1 (0.46) | PTK2BSMN1; SMN2MEN1KMT2ATSHR | |
| SCHEMBL13128980 | 0.76 | L3MBTL1 (0.50) | SMN1; SMN2MEN1KMT2AKDM4EPOLB | |
| SCHEMBL2740959 | 0.73 | CRHBP (0.51) | PTK2BSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL13128921 | 0.71 | MAPT (0.51) | SMN1; SMN2MEN1KMT2AKDM4EPOLB | |
| SCHEMBL7373672 | 0.67 | KDM4E (1.00) | PTK2BSMN1; SMN2KMT2AKDM4ETSHR | |
| SCHEMBL3718315 | 0.67 | KDM4E (0.70) | PTK2BSMN1; SMN2MEN1KMT2AKDM4E | |
| SCHEMBL27181401 | 0.66 | KMT2A (0.71) | SMN1; SMN2MEN1KMT2AKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100249135-A1 | SULFONAMIDES AND THEIR USE AS A MEDICAMENT | THE GENETICS COMPANY, INC. (CH) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249135-A1 | SULFONAMIDES AND THEIR USE AS A MEDICAMENT | BCOR, CBR3, SULT1E1 | PTK2B 2888/4885SMN1; SMN2 2187/4885MEN1 1381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.